Lower Arterial Cross-Sectional Area of Carotid and Vertebral Arteries and Higher Frequency of Secondary Neck Vessels Are Associated with Multiple Sclerosis

References

1. 1.↵
   2. Lucchinetti CF,
   3. Bruck W,
   4. Lassmann H

   . Evidence for pathogenic heterogeneity in multiple sclerosis. Ann Neurol 2004;56:308 doi:10.1002/ana.20182 pmid:15293289

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Xia Z,
   3. White CC,
   4. Owen EK, et al

   . Genes and Environment in Multiple Sclerosis project: a platform to investigate multiple sclerosis risk. Ann Neurol 2016;79:178–89 doi:10.1002/ana.24560 pmid:26583565

   CrossRefPubMed
3. 3.↵
   2. Marrie RA,
   3. Reider N,
   4. Cohen J, et al

   . A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis. Mult Scler 2015;21:318–31 doi:10.1177/1352458514564485 pmid:25533300

   CrossRefPubMed
4. 4.↵
   2. Klaren RE,
   3. Hubbard EA,
   4. Wetter NC, et al

   . Objectively measured sedentary behavior and brain volumetric measurements in multiple sclerosis. Neurodegener Dis Manag 2017;7:31–37 doi:10.2217/nmt-2016-0036 pmid:28074683

   CrossRefPubMed
5. 5.↵
   2. Dagan A,
   3. Gringouz I,
   4. Kliers I, et al

   . Disability progression in multiple sclerosis is affected by the emergence of comorbid arterial hypertension. J Clin Neurol 2016;12:345–50 doi:10.3988/jcn.2016.12.3.345 pmid:27273922

   CrossRefPubMed
6. 6.↵
   2. Kappus N,
   3. Weinstock-Guttman B,
   4. Hagemeier J, et al

   . Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 2016;87:181–87 doi:10.1136/jnnp-2014-310051 pmid:25722366

   Abstract/FREE Full Text
7. 7.↵
   2. Zivadinov R,
   3. Weinstock-Guttman B,
   4. Hashmi K, et al

   . Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis. Neurology 2009;73:504–10 doi:10.1212/WNL.0b013e3181b2a706 pmid:19687451

   Abstract/FREE Full Text
8. 8.↵
   2. Weinstock-Guttman B,
   3. Zivadinov R,
   4. Mahfooz N, et al

   . Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation 2011;8:127 doi:10.1186/1742-2094-8-127 pmid:21970791

   CrossRefPubMed
9. 9.↵
   2. Kavak KS,
   3. Teter BE,
   4. Hagemeier J, et al

   ; New York State Multiple Sclerosis Consortium. Higher weight in adolescence and young adulthood is associated with an earlier age at multiple sclerosis onset. Mult Scler 2015;21:858–65 doi:10.1177/1352458514555787 pmid:25392327

   CrossRefPubMed
10. 10.↵
    2. Thormann A,
    3. Magyari M,
    4. Koch-Henriksen N, et al

    . Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark. J Neurol 2016;263:2484–93 doi:10.1007/s00415-016-8295-9 pmid:27699465

    CrossRefPubMed
11. 11.↵
    2. D'Haeseleer M,
    3. Hostenbach S,
    4. Peeters I, et al

    . Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis? J Cereb Blood Flow Metab 2015;35:1406–10 doi:10.1038/jcbfm.2015.131 pmid:26104292

    CrossRefPubMed
12. 12.↵
    2. Sun X,
    3. Tanaka M,
    4. Kondo S, et al

    . Clinical significance of reduced cerebral metabolism in multiple sclerosis: a combined PET and MRI study. Ann Nucl Med 1998;12:89–94 doi:10.1007/BF03164835 pmid:9637279

    CrossRefPubMed
13. 13.↵
    2. Marshall O,
    3. Lu H,
    4. Brisset JC, et al

    . Impaired cerebrovascular reactivity in multiple sclerosis. JAMA Neurol 2014;71:1275–81 doi:10.1001/jamaneurol.2014.1668 pmid:25133874

    CrossRefPubMed
14. 14.↵
    2. Marshall O,
    3. Chawla S,
    4. Lu H, et al

    . Cerebral blood flow modulation insufficiency in brain networks in multiple sclerosis: a hypercapnia MRI study. J Cereb Blood Flow Metab 2016;36:2087–95 doi:10.1177/0271678X16654922 pmid:27306754

    CrossRefPubMed
15. 15.↵
    2. Sadeghian M,
    3. Mastrolia V,
    4. Rezaei Haddad A, et al

    . Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis. Sci Rep 2016;6:33249 doi:10.1038/srep33249 pmid:27624721

    CrossRefPubMed
16. 16.↵
    2. Zivadinov R,
    3. Ramasamy DP,
    4. Benedict RR, et al

    . Cerebral microbleeds in multiple sclerosis evaluated on susceptibility-weighted images and quantitative susceptibility maps: a case-control study. Radiology 2016;281:884–95 doi:10.1148/radiol.2016160060 pmid:27308776

    CrossRefPubMed
17. 17.↵
    2. Polman CH,
    3. Reingold SC,
    4. Banwell B, et al

    . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302 doi:10.1002/ana.22366 pmid:21387374

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Chobanian AV,
    3. Bakris GL,
    4. Black HR, et al

    ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206–52 doi:10.1161/01.HYP.0000107251.49515.c2 pmid:14656957

    Abstract/FREE Full Text
19. 19.↵
    2. Gisolf J,
    3. van Lieshout JJ,
    4. van Heusden K, et al

    . Human cerebral venous outflow pathway depends on posture and central venous pressure. J Physiol 2004;560:317–27 doi:10.1113/jphysiol.2004.070409 pmid:15284348

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Magnano ,
    3. Belov ,
    4. Krawiecki J, et al

    . Internal jugular vein cross-sectional area enlargement is associated with aging in healthy individuals. PLoS One 2016;11:e0149532 doi:10.1371/journal.pone.0149532 pmid:26895434

    CrossRefPubMed
21. 21.↵
    2. Allen NB,
    3. Lichtman JH,
    4. Cohen HW, et al

    . Vascular disease among hospitalized multiple sclerosis patients. Neuroepidemiology 2008;30:234–38 doi:10.1159/000128103 pmid:18437030

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Christiansen CF

    . Risk of vascular disease in patients with multiple sclerosis: a review. Neurol Res 2012;34:746–53 doi:10.1179/1743132812Y.0000000051 pmid:22709796

    CrossRefPubMed
23. 23.↵
    2. Ranadive SM,
    3. Yan H,
    4. Weikert M, et al

    . Vascular dysfunction and physical activity in multiple sclerosis. Med Sci Sports Exerc 2012;44:238–43 doi:10.1249/MSS.0b013e31822d7997 pmid:21775908

    CrossRefPubMed
24. 24.↵
    2. Minagar A,
    3. Jy W,
    4. Jimenez JJ, et al

    . Multiple sclerosis as a vascular disease. Neurol Res 2006;28:230–35 doi:10.1179/016164106X98080 pmid:16687046

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Feng W,
    3. Utriainen D,
    4. Trifan G, et al

    . Quantitative flow measurements in the internal jugular veins of multiple sclerosis patients using magnetic resonance imaging. Rev Recent Clin Trials 2012;7:117–26 doi:10.2174/157488712800100206 pmid:22356242

    CrossRefPubMed
26. 26.↵
    2. Haacke EM,
    3. Feng W,
    4. Utriainen D, et al

    . Patients with multiple sclerosis with structural venous abnormalities on MR imaging exhibit an abnormal flow distribution of the internal jugular veins. J Vasc Interv Radiol 2012;23:60–68.e1–3 doi:10.1016/j.jvir.2011.09.027 pmid:22221473

    CrossRefPubMed
27. 27.↵
    2. ElSankari S,
    3. Balédent O,
    4. van Pesch V, et al

    . Concomitant analysis of arterial, venous, and CSF flows using phase-contrast MRI: a quantitative comparison between MS patients and healthy controls. J Cereb Blood Flow Metab 2013;33:1314–21 doi:10.1038/jcbfm.2013.95 pmid:23778162

    CrossRefPubMed
28. 28.↵
    2. Narayana PA,
    3. Zhou Y,
    4. Hasan KM, et al

    . Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis. Mult Scler 2014;20:365–73 doi:10.1177/1352458513495936 pmid:23836878

    CrossRefPubMed
29. 29.↵
    2. Debernard L,
    3. Melzer TR,
    4. Van Stockum S, et al

    . Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2014;85:544–51 doi:10.1136/jnnp-2013-305612 pmid:24039024

    Abstract/FREE Full Text
30. 30.↵
    2. Salinet AS,
    3. Robinson TG,
    4. Panerai RB

    . Effects of cerebral ischemia on human neurovascular coupling, CO2 reactivity, and dynamic cerebral autoregulation. J Appl Physiol (1985) 2015;118:170–77 doi:10.1152/japplphysiol.00620.2014 pmid:25593216

    CrossRefPubMed
31. 31.↵
    2. Lu H,
    3. Xu F,
    4. Rodrigue KM, et al

    . Alterations in cerebral metabolic rate and blood supply across the adult lifespan. Cereb Cortex 2011;21:1426–34 doi:10.1093/cercor/bhq224 pmid:21051551

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Prinster A,
    3. Quarantelli M,
    4. Orefice G, et al

    . Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. Neuroimage 2006;29:859–67 doi:10.1016/j.neuroimage.2005.08.034 pmid:16203159

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Zivadinov R,
    3. Lopez-Soriano A,
    4. Weinstock-Guttman B, et al

    . Use of MR venography for characterization of the extracranial venous system in patients with multiple sclerosis and healthy control subjects. Radiology 2011;258:562–70 doi:10.1148/radiol.10101387 pmid:21177394

    CrossRefPubMed
34. 34.↵
    2. Wattjes MP,
    3. van Oosten BW,
    4. de Graaf WL, et al

    . No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study. J Neurol Neurosurg Psychiatry 2011;82:429–35 doi:10.1136/jnnp.2010.223479 pmid:20980483

    Abstract/FREE Full Text
35. 35.↵
    2. McTaggart RA,
    3. Fischbein NJ,
    4. Elkins CJ, et al

    . Extracranial venous drainage patterns in patients with multiple sclerosis and healthy controls. AJNR Am J Neuroradiol 2012;33:1615–20 doi:10.3174/ajnr.A3097 pmid:22517280

    Abstract/FREE Full Text
36. 36.↵
    2. Zaharchuk G,
    3. Fischbein NJ,
    4. Rosenberg J, et al

    . Comparison of MR and contrast venography of the cervical venous system in multiple sclerosis. AJNR Am J Neuroradiol 2011;32:1482–89 doi:10.3174/ajnr.A2549 pmid:21757521

    Abstract/FREE Full Text
37. 37.↵
    2. Buch K,
    3. Groller R,
    4. Nadgir RN, et al

    . Variability in the cross-sectional area and narrowing of the internal jugular vein in patients without multiple sclerosis. AJR Am J Roentgenol 2016;206:1082–86 pmid:26958902

    CrossRefPubMed
38. 38.↵
    2. Sethi SK,
    3. Daugherty AM,
    4. Gadda G, et al

    . Jugular anomalies in multiple sclerosis are associated with increased collateral venous flow. AJNR Am J Neuroradiol 2017;38:1617–22 doi:10.3174/ajnr.A5219 pmid:28546249

    Abstract/FREE Full Text
39. 39.↵
    2. Magnano C,
    3. Belov P,
    4. Krawiecki J, et al

    . Internal jugular vein narrowing and body mass index in healthy individuals and multiple sclerosis patients. Veins and Lymphatics 2014;3:4632 doi:10.4081/vl.2014.4632

    CrossRef
40. 40.↵
    2. Koerselman J,
    3. van der Graaf Y,
    4. de Jaegere PP, et al

    . Coronary collaterals: an important and underexposed aspect of coronary artery disease. Circulation 2003;107:2507–11 pmid:12756191

    FREE Full Text
41. 41.↵
    2. la Sala A,
    3. Pontecorvo L,
    4. Agresta A, et al

    . Regulation of collateral blood vessel development by the innate and adaptive immune system. Trends Mol Med 2012;18:494–501 doi:10.1016/j.molmed.2012.06.007 pmid:22818027

    CrossRefPubMed